For the runner who
hypo'd at mile 22.
and finished anyway. InRange reads each run against IOB and trend so the same finish line doesn't cost the same crash.
for runners with Type 1 Diabetes
InRange is a training practice for runners with T1D — built around your Dexcom or Libre, your pump or MDI, and the run you have today. Read-only. Never insulin.
Inspired byLancet T1D Exercise Consensus (2017)TidepoolType One Run
fig. 1What you see at mile 7.
I’ve finished marathons. I’ve finished marathons crying because of the hypo. I want a tool that knows the difference.
For the runner who
hypo'd at mile 22.
and finished anyway. InRange reads each run against IOB and trend so the same finish line doesn't cost the same crash.
For the endo who
has never seen a marathon report.
and is doing their best with a fasting A1c. Your 90-day InRange export puts running on the chart, in the language the appointment expects.
For the morning you're
tired of explaining.
what running does to your numbers. InRange writes it down so you can stop translating yourself for everyone in the loop.

fig. 2Mile seven, in-range. The run reads its own conditions.
the screen at mile 7
You’re trending steady at 112. Your watch shows pace. Your pump shows IOB. Nothing shows them together. InRange does.
No tap-to-log. No carb math at mile 7. InRange reads what your CGM and pump are already saying and writes the next decision in one sentence: hold pace, reassess at 9.
one run, one page
Your glucose trace overlaid on the route. Fuel and bolus events as pins. The minute the wheels almost came off — and the minute they didn’t.
Shareable with the people you choose. Never published. The day-report exists because most run logs forget about glucose, and most glucose logs forget about the run.
the page your endo earns time on
The metrics your endo grades you on — TIR, TBR, GMI, CV, mean — in one band. Then the page they’ve never seen before: weekly mileage vs. TIR.
The conversation stops being a translation exercise and starts being a clinical one. PDF/A-3, RFC 3161 timestamped. Archival format. Their fax machine can read it.
“Exercise is well-established as a cornerstone of management for type 1 diabetes.” Riddell, Gallen, Smart, et al. · The Lancet Diabetes & Endocrinology · 5(5):377–390 (2017)
Dear T1D runner,
changelog · 0.0.12026-05-22
Each of us has lived next to a condition that running helped. When we read the Lancet T1D exercise consensus — written by the people who actually train athletes with T1 — we recognized the pattern. The same intervention worked, in different bodies, in different contexts. The framework was already there. The product wasn’t.
We don’t have T1D. We aren’t pretending to. We built InRange with endocrinologists, in conversation with the T1 running community, and read-only on top of the devices you already trust — Dexcom, Libre, Omnipod, Tandem. InRange never touches insulin. InRange never moralizes a number.
InRange is for the runner whose glucose pattern is already part of their body. The first version is small on purpose. Three artifacts, one signal, one page for your endo. We ship the rest with you.
InRange is being built quietly. Leave an email and we’ll send a single note when private beta opens for runners with Type 1 Diabetes.